Global bioimplants market forecast
Technavio’s market research report identifies the increasing adoption of technologically advanced products to be one of the primary growth drivers for the global bioimplants market. Advances in biomedical sciences are consequent in biomaterials that are biodegradable, bioactive, and biologic. Supported by technological advances, the availability of antibiotic-coated bio-implants, microchip-controlled bio-implants, and advances in molecular imaging, will contribute to the widespread acceptance of bioimplants since they detect specific medical parameters and take immediate therapeutic action. According to the bioimplants market analysis, our analysts predict that this market will grow at a CAGR of more than 10% by 2021.
Minimally invasive surgeries are beneficial in reducing the incidences of post-surgical complications, quick recovery, and shorter hospital stay. Minimally invasive procedures such as laser surgery, endoscopy, and laparoscopy create small incisions, significantly helps in reducing pain and morbidity, and improves postoperative recovery. The convenience of minimally invasive surgeries provides traction to the use of small bioimplants, smart tools, and devices. This will increase the preference for minimally invasive surgeries, which will be one of the key bioimplants market trends that will gain traction in the bioimplants market during the next few years.
Competitive landscape and key vendors
The bioimplants market is highly competitive due to the presence of several international, regional, and local vendors. These vendors are increasingly competing against each other based on factors such as R&D investments, development of bioelectric implants, and partnerships and M&A. They are also developing biocompatible biomaterials and bioelectronic implants to upgrade their technological expertise. Increasing adoption of technology in emerging markets and the entry of new vendors will further intensify the competitiveness of the biological implants market.
Key vendors in this market are
- Abbott
- DePuy Synthes
- Medtronic
- Stryker
- Zimmer Biomet
Other prominent vendors in the market include B. Braun, Cook Medical, Corin, C. R. Bard, Edwards Lifesciences, FH Orthopedics, Kasios, KLS martin GROUP, Mediplus, W. L. Gore & Associates, and Wright Medical technology.
Segmentation by product type and analysis of the bioimplants market
- Cardiovascular bioimplants
- Dental bioimplants
- Ophthalmic bioimplants
- Neurostimulation bioimplants
- Orthopedic bioimplants
High blood pressure (BP), lack of physical exercise, and the increasing prevalence of obesity, hereditary diseases, and diabetes results in cardiovascular diseases (CVD). Also, the hospital admissions for CVDs in the UK has increased. CVDs are one of the leading causes of death in the country according to the national health service (NHS). This, in turn, will boost the sales of cardiovascular bioimplants, contributing positively towards the growth of the biological implants market.
Segmentation by end-user and analysis of the bioimplants market
- Hospitals
- ASCs
- Research institutions
Hospitals are increasingly focusing on increasing their revenue by recommending minimally invasive surgeries that use bioimplants. For instance, the prevalence of conditions such as heart arrhythmia requires cardiac pacemakers to stabilize the heart rate. The hospitals segment will continue to be the largest end-user during the estimated period due to the high number of bio implantation surgeries in tertiary care hospitals in emerging countries such as India and China.
Key questions answered in the report include
- What will the market size and the growth rate be in 2021?
- What are the key factors driving the global bioimplants market?
- What are the key market trends impacting the growth of the global bioimplants market?
- What are the challenges to market growth?
- Who are the key vendors in the global bioimplants market?
- What are the market opportunities and threats faced by the vendors in the global bioimplants market?
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
- What are the key outcomes of the five forces analysis of the global bioimplants market?
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: MARKET LANDSCAPE
- Overview
- Market size and forecast
- Five forces analysis
PART 06: SEGMENTATION BY PRODUCT TYPE
- Overview
- Cardiovascular bioimplants
- Orthopedic bioimplants
- Dental bioimplants
- Ophthalmic bioimplants
- Neurostimulation bioimplants
- Others
PART 07: SEGMENTATION BY IMPLANT MATERIAL
- Overview
- Ceramics
- Biomaterial metals
- Alloys
- Biological materials
- Polymers
PART 08: SEGMENTATION BY END-USER
- Overview
- Comparison by end-user
- Hospitals
- ASCs
- Research institutions
- Market opportunity by End-user
PART 09: SEGMENTATION BY GEOGRAPHY
- Overview
- Regional comparison
- Americas
- EMEA
- APAC
- Key leading countries
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Increasing demand for minimally invasive surgeries
- Rise of medical tourism
PART 13: VENDOR LANDSCAPE
- Competitive landscape
- Other prominent vendors
PART 14: VENDOR ANALYSIS
- Vendor overview
- Abbott
- DePuy Synthes
- Medtronic
- Stryker
- Zimmer Biomet
PART 15: APPENDIX